𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low prevalence of human T-cell leukemia virus-I and -II infection among drug users in Amsterdam, the Netherlands

✍ Scribed by Mrs. J. A. R. Van Den Hoek; E. J. M. Al; J. G. Huisman; J. Goudsmit; R. A. Coutinho

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
395 KB
Volume
34
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

The prevalence of human T-cell leukaemia virus-I and -II infection was studied in a cohort of 346 intravenous and nonintravenous drug users in Amsterdam. Three participants (0.86%) had antibodies to HTLV-I by two commercially available HTLV-I enzyme immunoassays (EIA). Infection in these three subjects was confirmed by radioimmunoprecipitation assay. In the immunoblot study, only two of the three subjects were considered positive, since the serum of the third subject had antibodies to p24 only. By means of the polymerase chain reaction two participants (male intravenous drug users infected with human immunodeficiency virus; HIV) appeared to be infected with HTLV-I and one subject (a male nonintravenous drug user from Surinam) with HTLV-II. It is concluded that HTLV-I and HTLV-II circulate sporadically among drug users in Amsterdam and that risky injecting behaviour, which led to an HIV epidemic among intravenous drug users, has not led so far to an appreciable transmission of the other retroviruses among this group.

πŸ“œ SIMILAR VOLUMES

Prevalence of human T-cell leukemia viru
Prevalence of human T-cell leukemia virus types I and II in Switzerland
✍ JΓΌrg BΓΆni; Leslie R. Bisset; Johann J. Burckhardt; Helen I. Joller-Jemelka; Phil πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 1 views

## Abstract The retroviruses human immunodeficiency virus (HIV)‐1/2 and human T‐cell leukemia virus (HTLV)‐I/II share modes of transmission, suggesting that efforts to monitor the current HIV‐1 epidemic in Switzerland should be complemented by assessment of HTLV‐I/II prevalence. This study presents

Changes in risk behavior and dynamics of
Changes in risk behavior and dynamics of hepatitis C virus infections among young drug users in Amsterdam, the Netherlands
✍ Thijs J.W. van de Laar; Miranda W. Langendam; Sylvia M. Bruisten; Esther A.E. We πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 2 views

To elucidate the character and magnitude of the hepatitis C virus (HCV) epidemic among drug users in Amsterdam, 197 young drug users from the period 2000 to 2004 were compared with 215 counterparts from 1985 to 1989. Although injection risk behavior and HCV seroprevalence decreased sharply over time